Human Anti-D Rh(D) Immunoglobulin
For more information about Rh(D) Immunoglobulin-VF, please visit the
Australian Red Cross Blood Servicewebsite
NHMRC website to obtain the Immunisation handbook
Rh(D) Immunoglobulin-VF (Anti-D) is a human immunoglobulin preparation for intramuscular administration.
Rh(D) Immunoglobulin-VF is prepared from blood obtained from voluntary and non-remunerated (unpaid) donors. Rh(D) Immunoglobulin-VF contains proteins called antibodies which help to suppress the unwanted immune response in an Rh(D) negative woman following her exposure to Rh(D) positive red cells.
For example, if a pregnant woman has an Rh(D) negative blood group and her baby is Rh(D) positive, the baby's blood is incompatible with the mother’s. This could lead to reduced red blood cells, brain damage and other serious complications in the baby. This condition is known as Haemolytic Disease of the Newborn.
Rh(D) Immunoglobulin-VF can be given to Rh(D) negative women during pregnancy and following birth of an Rh(D) positive baby to help prevent Haemolytic Disease of the Newborn.
Rh(D) Immunoglobulin-VF is sometimes given on other occasions when a woman of child-bearing age may become exposed to Rh(D) positive blood: for example, after blood transfusion, amniocentesis (taking a sample of the fluid surrounding the unborn baby), miscarriage or stillbirth.
Rh(D) Immunoglobulin-VF is available only with a doctor’s prescription.
Who is this information for?
This information is relevant in Australia and is intended for health care professionals or people who have been prescribed this product.
Consumer Medicine Information
The Consumer Medicine Information is a leaflet written for people who have been prescribed Rh(D) Immunoglobulin-VF and contains information about the medicine including:
- What Rh(D) Immunoglobulin-VF is used for
- How Rh(D) Immunoglobulin-VF works
- How Rh(D) Immunoglobulin-VF is given
- Side effects
- Further Information
Rh(D) Immunoglobulin-VF Consumer Medicine Information (PDF, 0.04 MB)
Product Information contains information to ensure the safe and effective use of a medicine. This document is approved by the Therapeutic Goods Administration and made available by CSL for you if you are a:
- qualified healthcare professional; or
- consumer, provided you have read the Consumer Medicine Information for the product; want further information on the product; and agree to consult with your healthcare professional if you have any questions in relation to the Product Information.
Rh(D) Immunoglobulin-VF Product Information (PDF, 0.07 MB)
Last Updated: 30/12/2012